IQVIA - Company Intelligence Profile
Industry: Hospitals and Health Care | Founded: not publicly disclosed | HQ: Durham, United States
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality...
Datakart tracks firmographic, hiring, traffic, technology, funding, review, and leadership signals for IQVIA to help teams evaluate the account with useful business context.
Company Snapshot
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
Founded
Employee count
Monthly website visits
Open roles
Company Snapshot Details
Business signals that help qualify IQVIA
This profile combines firmographic, traffic, hiring, employee, review, compensation, technology, funding, leadership, and product availability signals so visitors can answer practical business questions without hunting across multiple data sources.
Last refreshed 2026-04-22 | 61K search volume | Domain iqvia.com
IQVIA identity, aliases, ownership, and taxonomy
This section makes the entity easier to verify: canonical domains, alternate names, descriptions, ownership flags, parent or acquirer context, industry codes, and source-level social reach are grouped together.
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
IQVIA is a global community that invests and commits to advancing human health. They provide solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.
Solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.
LinkedIn followers
2.6M
Latest linkedin followers value available from the source dataset.
Owler followers
4.9K
Latest owler followers value available from the source dataset.
Technologies detected
1.2K
Latest technologies detected value available from the source dataset.
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
Yes
Is Public
Company alias
iqvia
Company Name Alias
Company alias
pilgrim quality solutions
Company Name Alias
Company alias
iqvia, inc.
Company Name Alias
Company alias
iqvia holdings inc
Company Name Alias
Website alias
https://www.iqvia.com
Website Alias
Website alias
https://www.iqvia.com/
Website Alias
Canonical website
https://www.iqvia.com
website
Website domain
iqvia.com
Website Domain
Unique website
Yes
Unique Website
Unique domain
Yes
Unique Domain
Expired domain
No
Expired Domain
LinkedIn shorthand
iqvia
Canonical LinkedIn Shorthand Name
Source ID
4057
Source ID
UUID
3JNE5NB0DE1P95B0XXVRR064PD
uuid
SIC code
87
SIC Codes
SIC code
873
SIC Codes
NAICS code
54
NAICS Codes
NAICS code
541
NAICS Codes
Industry
Hospitals and Health Care
industry
Categories and keywords
['healthcare', 'health care software', 'healthcare commercial intelligence software', 'iqvia', 'healthcare commercial intelligence', 'technology', 'consulting', 'clinical development', 'treatments', 'connected intelligence', 'life sciences', 'patients', 'clinical-research', 'cloud-services', 'data-collection', 'data-management', 'enterprise-software', 'healthtech', 'platform', 'analytics', 'health care', 'life science']
Categories And Keywords
LinkedIn followers
2.6M
Followers Count LinkedIn
Owler followers
4.9K
Followers Count Owler
Primary location
2400 Ellis Rd; Durham, North Carolina 27703, US
Office location
2400 Ellis Rd; Durham, North Carolina, United States
Office location
4820 Emperor Boulevard; Durham, 27703, United States
Office location
Danbury, Connecticut, United States
Office location
4820 Emperor Blvd; Durham, North Carolina 27703, United States
IQVIA revenue, funding, IPO, and acquisition history
Financial signals are grouped as an analyst-style view: revenue sources, income statement rows, funding rounds, acquisition activity, IPO fields, stock listing context, and ownership structure.
Source 5
$16.3B
Annual revenue
IPO date
2017-11-15
IPO Date
Operating status
Active
Independent Company
Company type
Public Company
type
Ownership status
Public
Ownership Status
Public company
Yes
Is Public
FY, 2025
Fiscal Year
Primary value
Revenue: $16.3B
Additional metrics
Gross profit: $5.4B; EBIT: $2.2B; Net income: $1.4B; Operating expense: $3.2B; Gross margin: 33.3%; EPS: 7.84
Q3, 2025
Q3
Primary value
Revenue: $4.1B
Additional metrics
Gross profit: $1.4B; EBIT: $553M; Net income: $332M; Operating expense: $820M; Gross margin: 33.5%; EPS: 1.93
Q3, 2025
Q3
Primary value
Revenue: $4.1B
Additional metrics
EBIT: $553M; Net income: $332M; Operating expense: $514M; EPS: 1.93
Q2, 2025
Q2
Primary value
Revenue: $4B
Additional metrics
Gross profit: $1.3B; EBIT: $506M; Net income: $266M; Operating expense: $817M; Gross margin: 32.9%; EPS: 1.54
Q2, 2025
Q2
Primary value
Revenue: $4B
Additional metrics
EBIT: $506M; Net income: $266M; Operating expense: $509M; EPS: 1.54
Q1, 2025
Q1
Primary value
Revenue: $3.8B
Additional metrics
Gross profit: $1.3B; EBIT: $496M; Net income: $249M; Operating expense: $802M; Gross margin: 33.9%; EPS: 1.4
Q1, 2025
Q1
Primary value
Revenue: $3.8B
Additional metrics
EBIT: $496M; Net income: $249M; Operating expense: $508M; EPS: 1.4
FY, 2024
Fiscal Year
Primary value
Revenue: $15.4B
Additional metrics
Gross profit: $5.4B; EBIT: $2.2B; Net income: $1.4B; Operating expense: $3.2B; Gross margin: 34.9%; EPS: 7.49
Q3, 2024
Q3
Primary value
Revenue: $3.9B
Additional metrics
Gross profit: $915M; EBIT: $550M; Net income: $285M; Operating expense: $828M; Gross margin: 23.5%; EPS: 1.55
Q2, 2024
Q2
Primary value
Revenue: $3.8B
Additional metrics
Gross profit: $1.3B; EBIT: $520M; Net income: $363M; Operating expense: $806M; Gross margin: 34.8%; EPS: 1.97
Q1, 2024
Q1
Primary value
Revenue: $3.7B
Additional metrics
Gross profit: $1.3B; EBIT: $506M; Net income: $288M; Operating expense: $787M; Gross margin: 34.6%; EPS: 1.56
FY, 2023
Fiscal Year
Primary value
Revenue: $15B
Additional metrics
Gross profit: $5.2B; EBIT: $2B; Net income: $1.4B; Operating expense: $3.3B; Gross margin: 35.0%; EPS: 7.29
| Period | Primary value | Additional metrics |
|---|---|---|
FY, 2025 Fiscal Year | Revenue: $16.3B | Gross profit: $5.4B; EBIT: $2.2B; Net income: $1.4B; Operating expense: $3.2B; Gross margin: 33.3%; EPS: 7.84 |
Q3, 2025 Q3 | Revenue: $4.1B | Gross profit: $1.4B; EBIT: $553M; Net income: $332M; Operating expense: $820M; Gross margin: 33.5%; EPS: 1.93 |
Q3, 2025 Q3 | Revenue: $4.1B | EBIT: $553M; Net income: $332M; Operating expense: $514M; EPS: 1.93 |
Q2, 2025 Q2 | Revenue: $4B | Gross profit: $1.3B; EBIT: $506M; Net income: $266M; Operating expense: $817M; Gross margin: 32.9%; EPS: 1.54 |
Q2, 2025 Q2 | Revenue: $4B | EBIT: $506M; Net income: $266M; Operating expense: $509M; EPS: 1.54 |
Q1, 2025 Q1 | Revenue: $3.8B | Gross profit: $1.3B; EBIT: $496M; Net income: $249M; Operating expense: $802M; Gross margin: 33.9%; EPS: 1.4 |
Q1, 2025 Q1 | Revenue: $3.8B | EBIT: $496M; Net income: $249M; Operating expense: $508M; EPS: 1.4 |
FY, 2024 Fiscal Year | Revenue: $15.4B | Gross profit: $5.4B; EBIT: $2.2B; Net income: $1.4B; Operating expense: $3.2B; Gross margin: 34.9%; EPS: 7.49 |
Q3, 2024 Q3 | Revenue: $3.9B | Gross profit: $915M; EBIT: $550M; Net income: $285M; Operating expense: $828M; Gross margin: 23.5%; EPS: 1.55 |
Q2, 2024 Q2 | Revenue: $3.8B | Gross profit: $1.3B; EBIT: $520M; Net income: $363M; Operating expense: $806M; Gross margin: 34.8%; EPS: 1.97 |
Q1, 2024 Q1 | Revenue: $3.7B | Gross profit: $1.3B; EBIT: $506M; Net income: $288M; Operating expense: $787M; Gross margin: 34.6%; EPS: 1.56 |
FY, 2023 Fiscal Year | Revenue: $15B | Gross profit: $5.2B; EBIT: $2B; Net income: $1.4B; Operating expense: $3.3B; Gross margin: 35.0%; EPS: 7.29 |
Post-IPO Debt
$2B
2025-07-02
Post-IPO Debt
$2B
2025-06-01
Post-IPO Equity
$2.6M
2023-12-01 | L2 Asset Management
Post-IPO Debt
$500M
2023-11-14
Post-IPO Debt
$1B
2023-05-18
Post-IPO Equity
2019-08-08 | CPP Investment Board Europe, TPG, Bain Capital
Corporate Round
$9B
2016-05-01 | IMS Health
Grant
$1M
2013-06-01
Post-IPO Equity
2013-05-01
Debt Financing
$525M
2009-12-01 | Citi, Morgan Stanley
Venture Round
2007-12-01 | TPG, 3i Group
OpenApp
Acquisition
2023-10-08 | Acquisition List Source 2
Pharmaspectra
$100M
2022-08-12 | Acquisition List Source 1
Pharmaspectra
$100M
2022-08-01 | Acquisition List Source 2
Pharmaspectra, LLC
$100M
2022-08-01 | Acquisition List Source 5
Q2 Solutions
$760M
2021-04-01 | Acquisition List Source 1
AllCare Plus Pharmacy
Acquisition
2020-09-16 | Acquisition List Source 2
Linguamatics
Acquisition
2019-02-12 | Acquisition List Source 1
Linguamatics Limited
Acquisition
2019-02-01 | Acquisition List Source 5
Advanced Health Media LLC
Acquisition
2018-05-31 | Acquisition List Source 1
Advanced Health Media
Acquisition
2018-05-31 | Acquisition List Source 2
DrugDev
Acquisition
2017-11-16 | Acquisition List Source 1
Pilgrim Quality Solutions
Acquisition
2017-10-05 | Acquisition List Source 2
Themis Analytics
Acquisition
2017-07-15 | Acquisition List Source 2
STI Technologies
$200M
2017-02-23 | Acquisition List Source 2
Aileron Solutions
Acquisition
2014-07-01 | Acquisition List Source 1
Novella Clinical LLC
Acquisition
2013-08-14 | Acquisition List Source 1
IQVIA Solutions Finance UK V Ltd.
Acquisition
Acquisition List Source 1
Pharmaspectra Group Ltd.
Acquisition
Acquisition List Source 1
IQVIA Technology Services Ltd.
Acquisition
Acquisition List Source 1
Quintiles Commercial Laboratorio S.L.U.
Acquisition
Acquisition List Source 1
IQVIA Solutions UK Limited
Acquisition
Acquisition List Source 1
ClinTec International Pte Ltd.
Acquisition
Acquisition List Source 1
Asesorias IQVIA Solutions Chile Limitada
Acquisition
Acquisition List Source 1
Themis Limited
Acquisition
Acquisition List Source 1
PT IQVIA Solutions Indonesia
Acquisition
Acquisition List Source 1
PharmARC Inc.
Acquisition
Acquisition List Source 1
Grace Data Corp.
Acquisition
Acquisition List Source 1
ClinTec International Pty Ltd
Acquisition
Acquisition List Source 1
IQVIA Solutions Finance UK II Ltd.
Acquisition
Acquisition List Source 1
IQVIA Clinical, Filial af IQVIA Clinical AB
Acquisition
Acquisition List Source 1
IQVIA Solutions Italy
Acquisition
Acquisition List Source 1
IMS Health de Venezuela C.A.
Acquisition
Acquisition List Source 1
IQVIA RDS Pty. Ltd.
Acquisition
Acquisition List Source 1
IMS Health Uruguay S.A.
Acquisition
Acquisition List Source 1
Forcea NV
Acquisition
Acquisition List Source 1
ClinTec Gesellschaft fur Klinische Entwicklung GmbH
Acquisition
Acquisition List Source 1
IQVIA Consulting Solutions BV
Acquisition
Acquisition List Source 1
Rules-Based Medicine, Inc.
Acquisition
Acquisition List Source 1
Iqvia Solutions Taiwan Ltd.
Acquisition
Acquisition List Source 1
IQVIA Solutions Denmark AS
Acquisition
Acquisition List Source 1
ClinTec Austria GmbH
Acquisition
Acquisition List Source 1
IQVIA IES Europe Limited
Acquisition
Acquisition List Source 1
Clinical Insourcing Solutions Limited
Acquisition
Acquisition List Source 1
ClinTec Turkey Medikal ve Farmasotik Hizmetler Ticaret Limited Sirketi
Acquisition
Acquisition List Source 1
IQVIA RDS Malaysia Sdn. Bhd.
Acquisition
Acquisition List Source 1
IQVIA Solutions (NZ) Limited
Acquisition
Acquisition List Source 1
Market Dynamics, L.L.C.
Acquisition
Acquisition List Source 1
GCE Solutions International, LLC
Acquisition
Acquisition List Source 1
IMS Health Analytics Services Private Limited
Acquisition
Acquisition List Source 1
Quintiles Commercial Rus LLC
Acquisition
Acquisition List Source 1
IQVIA RDS Poland Sp. Zoo
Acquisition
Acquisition List Source 1
Q Squared Solutions S.A.
Acquisition
Acquisition List Source 1
IQVIA Solutions Pharmaceutical SRL
Acquisition
Acquisition List Source 1
Nexelis Laboratories Canada Inc.
Acquisition
Acquisition List Source 1
Kairos GmbH
Acquisition
Acquisition List Source 1
IQVIA RDS Asia Inc.
Acquisition
Acquisition List Source 1
IQVIA RDS Spain S.L.
Acquisition
Acquisition List Source 1
Q Squared Solutions KK
Acquisition
Acquisition List Source 1
iGuard, Inc.
Acquisition
Acquisition List Source 1
IQVIA Solutions Finance UK I Ltd.
Acquisition
Acquisition List Source 1
Cambridge Pharma Consultancy Inc.
Acquisition
Acquisition List Source 1
Evigrade - Health Care Research Consulting, Unipessoal, LDA
Acquisition
Acquisition List Source 1
IQVIA RDS Egypt LLC
Acquisition
Acquisition List Source 1
RedPharma SA
Acquisition
Acquisition List Source 1
EPID Research Oy
Acquisition
Acquisition List Source 1
MMK Communications Co., Ltd.
Acquisition
Acquisition List Source 1
IQVIA Integrated Services NL
Acquisition
Acquisition List Source 1
IQVIA RDS France SAS
Acquisition
Acquisition List Source 1
IQVIA Solutions Korea Ltd.
Acquisition
Acquisition List Source 1
Meridian Research Vietnam Ltd.
Acquisition
Acquisition List Source 1
IQVIA Solutions Bangladesh Limited
Acquisition
Acquisition List Source 1
Innovex Saglik Urunleri Pazarlame ve Hizmet Danismanlik Anonim Sirketi
Acquisition
Acquisition List Source 1
IQVIA Solutions Egypt Ltd.
Acquisition
Acquisition List Source 1
IQVIA RDS Colombia S.A.S.
Acquisition
Acquisition List Source 1
gradient.Systemintegration GmbH
Acquisition
Acquisition List Source 1
Silverbullet A/S
Acquisition
Acquisition List Source 1
IQVIA Solutions Enterprise Management Consulting (Hainan) Co., Ltd.
Acquisition
Acquisition List Source 1
Prioritis Limited
Acquisition
Acquisition List Source 1
Centrix Innovations (Pty) Ltd.
Acquisition
Acquisition List Source 1
Q Squared Solutions Holdings LLC
Acquisition
Acquisition List Source 1
PharmaSource Inc.
Acquisition
Acquisition List Source 1
IQVIA Solutions Kazakhstan LLC
Acquisition
Acquisition List Source 1
IQVIA Solutions Finland OY
Acquisition
Acquisition List Source 1
Asserta Centroamerica Medicion de Mercados, S.A.
Acquisition
Acquisition List Source 1
Benefit Holding, Inc.
Acquisition
Acquisition List Source 1
IQVIA Health Transformation Foundation
Acquisition
Acquisition List Source 1
Aposphäre GmbH
Acquisition
Acquisition List Source 1
ImmunXperts
Acquisition
Acquisition List Source 1
Dimensions Healthcare FZ-LLC
Acquisition
Acquisition List Source 1
IQVIA CSMS
Acquisition
Acquisition List Source 1
Prometheus Research, LLC
Acquisition
Acquisition List Source 1
Dimensions Healthcare Company Ltd
Acquisition
Acquisition List Source 1
IQVIA Information
Acquisition
Acquisition List Source 1
Privacy Analytics Inc.
Acquisition
Acquisition List Source 1
Quintiles Medical Development (Shanghai) Co., Ltd.
Acquisition
Acquisition List Source 1
IQVIA Holdings France SAS
Acquisition
Acquisition List Source 1
Qcare Site Services, Inc.
Acquisition
Acquisition List Source 1
Professional Pharmaceutical Marketing Services (Pty.) Ltd.
Acquisition
Acquisition List Source 1
IQVIA RDS Argentina S.R.L.
Acquisition
Acquisition List Source 1
IQVIA Solutions do Brasil Ltda.
Acquisition
Acquisition List Source 1
IQVIA II Technology Solutions Portugal, Unipessoal LDA
Acquisition
Acquisition List Source 1
PR Editions S.A.S.
Acquisition
Acquisition List Source 1
Operaciones Centralizadas Latinoamericana Limitada
Acquisition
Acquisition List Source 1
IQVIA RDS GmbH
Acquisition
Acquisition List Source 1
IMS HEALTH GROUP LIMITED
Acquisition
Acquisition List Source 1
IQVIA Technology Solutions (China) Co., Ltd.
Acquisition
Acquisition List Source 1
ALIMED Egeszsegugyi Szolgaltato Kft.
Acquisition
Acquisition List Source 1
IMS Health Paraguay SRL
Acquisition
Acquisition List Source 1
IQVIA IES Denmark ApS
Acquisition
Acquisition List Source 1
Polaris
Acquisition
Acquisition List Source 2
Web visibility, demand, and topics
Use these signals to understand discoverability, demand quality, search interest, and audience fit.
Monthly visits
1.3M
Latest monthly visits value available from the source dataset.
Global web rank
#35,830
Lower rank values indicate stronger web visibility in the source dataset.
Bounce rate
42.0%
Latest bounce rate value available from the source dataset.
Pages per visit
4.27
Latest pages per visit value available from the source dataset.
Average visit duration
3m 47s
Latest average visit duration value available from the source dataset.
Estimated monthly page views
5.5M
Derived estimate calculated as monthly visits multiplied by pages per visit.
iqvia
Associated search topic
iqvia careers
Associated search topic
iq via
Associated search topic
iqvia jobs
Associated search topic
npi registry
Associated search topic
LinkedIn followers
2.6M
Followers Count LinkedIn
Owler followers
4.9K
Followers Count Owler
Employees, hiring, attrition, and compensation
This section groups org scale, hiring motion, employee movement, department mix, and salary benchmarks so teams can qualify operating momentum and budget signals.
Employees
77.9K
Latest employees value available from the source dataset.
Inferred employees
51.6K
Latest inferred employees value available from the source dataset.
Open roles
2.7K
Latest open roles value available from the source dataset.
Departures
0
Latest departures value available from the source dataset.
Employee attrition rate
0.0%
Latest employee attrition rate value available from the source dataset.
Hiring intensity
34.9 roles / 1K employees
Derived signal showing open roles normalized by employee count.
Medical Advisor (血液内科)/ IQVIA Services
Open role
3974382898
Clinical Trial Manager - IQVIA Biotech
Open role
4321427650
Clinical Research Associate, Full Service
Open role
4321444642
Clinical Trial Manager - IQVIA Biotech
Open role
4321447274
Clinical Trial Manager - IQVIA Biotech
Open role
4321476946
Associate Clinical Project Manager, Sponsor Dedicated
Open role
4324949489
Data Team Lead/Senior Data Team Lead (M/W/D)
Open role
4325384309
Consultant - Primary Market Research
Open role
4325468045
Showing 8 of 18 available records.
Showing 8 of 10 available records.
Showing 8 of 10 available records.
Product readiness, customer proof, and employee sentiment
Product availability, public reviews, and employee sentiment help visitors understand whether the company is mature, documented, reviewable, and operationally healthy.
Product reviews
14
Latest product reviews value available from the source dataset.
Employee reviews
1
Latest employee reviews value available from the source dataset.
Employee rating
5.0
Latest review score available from the source dataset.
Is pricing information available?
Yes. The source snapshot lists pricing information for this company.
Source availability signal
Is a free trial listed?
No. The source snapshot does not list a free trial for this company.
Source availability signal
Can buyers request a demo?
No. The source snapshot does not list a demo motion for this company.
Source availability signal
Is the product downloadable?
No. The source snapshot does not list downloadable software for this company.
Source availability signal
Are mobile apps listed?
No. The source snapshot does not list mobile apps for this company.
Source availability signal
Is public documentation listed?
No. The source snapshot does not list public documentation for this company.
Source availability signal
Are online reviews listed?
No. The source snapshot does not list online reviews for this company.
Source availability signal
Technology, leadership, competitors, funding, and corporate activity
These data points help sales, partnerships, analysts, and researchers understand how the company operates, who surrounds it, and where it may be moving next.
Adobe Xd
Verified technology
Last verified 2026-05-04 | First seen 2025-02-20
Oracle Hyperion
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Visier
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Bynder
Verified technology
Last verified 2026-05-04 | First seen 2025-09-24
Heroku
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Axway
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Github
Verified technology
Last verified 2026-05-04 | First seen 2024-04-04
Powerpivot
Verified technology
Last verified 2026-05-04 | First seen 2025-08-17
Showing 8 of 24 available records.
Showing 8 of 12 available records.
Martha D. Ramirez
Clinical Trial Payments Lead
Niraj Prajapati
Associate Director
Arvind HS
Engineering Lead
Radhika Mergey
Product Owner - Audience Paltform
Maria Afrashte
Vice President
liesbet menten
Director Clinical Operations
Laura Pinto
Clinical Lead
Sushant Malhotra
Data Analytics And Insight Lead
Showing 8 of 12 available records.
Leah Nietubicz
Director, Clinical Data Management
Jan 2026
Bruna Bozzetto Closs
Associate Director Client Services
Mar 2026
Dávid Szilágyi
Consulting Country Lead, Hungary and Adria
Jan 2026
Todd Swerdlow
Vice President of Strategic Accounts
Jan 2026
Peter Sullivan
Director - IQVIA Digital
Mar 2026
Diego Ferrero
Assoc Director
Mar 2026
Angel Rabanal Fuentes
Sr Director Emerging Biopharma
Jan 2026
Ajay Kamra
Director
May 2026
Leah Nietubicz
Associate Director, Clinical Data Management
Jan 2026
Peter Sullivan
Director Technology Solutions
Mar 2026
Angel Rabanal Fuentes
Sr Account Director Intl Developed Markets and Patient/HCP Engagement lead, Pfizer
Dec 2025
Radovan Korec
Associate Director, Project Finance
Feb 2026
Ajay Kamra
Associate Director
May 2026
Matthew Gillis
Director, Business Development, Real-World Solutions
Feb 2026
Liz Kane
Associate Client Relationship Director
Feb 2026
Betty Michelson
Director, Sales Solutions, IQVIA Digital
Dec 2025
Primary location
2400 Ellis Rd; Durham, North Carolina 27703, US
Office location
2400 Ellis Rd; Durham, North Carolina, United States
Office location
4820 Emperor Boulevard; Durham, 27703, United States
Office location
Danbury, Connecticut, United States
Office location
4820 Emperor Blvd; Durham, North Carolina 27703, United States
FDA’s Rare Disease Evidence Principles (RDEP) build on existing guidance to provide greater clarity for ultra…
57 reactions; 4 comments
2026-04-20 | FDA’s Rare Disease Evidence Principles (RDEP) build on existing guidance to provide greater clarity for ultra-rare drug development. For sponsors working in small populations where randomized trials are often not feas…
Each year, many women dealing with chronic diseases get pregnant, with little evidence from clinical trials t…
82 reactions; 2 comments
2026-04-17 | Each year, many women dealing with chronic diseases get pregnant, with little evidence from clinical trials to support evidence based decision making for their ongoing treatment. In this white paper, IQVIA’s Joydeep Sa…
How is Real World Evidence shaping decisions across the product lifecycle? Join us April 28–29 for an IQVIA…
104 reactions
2026-04-16 | How is Real World Evidence shaping decisions across the product lifecycle? Join us April 28–29 for an IQVIA Virtual Conference exploring how regulators, payers, and patients are using RWE to gain insight and make decis…
IQVIA is now hiring for hundreds of clinical roles across our global teams. Find the role that's right for yo…
480 reactions; 21 comments
2026-04-16 | IQVIA is now hiring for hundreds of clinical roles across our global teams. Find the role that's right for you: https://bit.ly/41SvM7H #WeAreIQVIA
As generative AI reshapes how healthcare professionals (HCPs) access and prioritise medical evidence, traditi…
103 reactions; 5 comments
2026-04-15 | As generative AI reshapes how healthcare professionals (HCPs) access and prioritise medical evidence, traditional pharma customer engagement models are being challenged. This article outlines the implications for go to…
Looking forward to the exchange of ideas at Reuters Events Pharma Europe 2026 in just a few days! Join the co…
68 reactions
2026-04-15 | Looking forward to the exchange of ideas at Reuters Events Pharma Europe 2026 in just a few days! Join the conversation with IQVIA Commercial Solutions on commercialization and AI. Connect with us: https://lnkd.in/eT8KQ…
SIC code
87
SIC Codes
SIC code
873
SIC Codes
NAICS code
54
NAICS Codes
NAICS code
541
NAICS Codes
Industry
Hospitals and Health Care
industry
Categories and keywords
['healthcare', 'health care software', 'healthcare commercial intelligence software', 'iqvia', 'healthcare commercial intelligence', 'technology', 'consulting', 'clinical development', 'treatments', 'connected intelligence', 'life sciences', 'patients', 'clinical-research', 'cloud-services', 'data-collection', 'data-management', 'enterprise-software', 'healthtech', 'platform', 'analytics', 'health care', 'life science']
Categories And Keywords
IQVIA FAQs
Company profile
Want verified contact data for IQVIA?
Datakart.ai gives you verified email addresses, direct dials, and buying intent signals for key decision-makers at IQVIA and 1,700+ other companies.